Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Staels

Showing results (501-510 of 594) with videos related to

Pageof 60
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2008
Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosisMarcia L E MacDonald, Miranda van Eck, Reeni B Hildebrand, et al.
JHEP Reports : Innovation in Hepatology|February 22, 2021
NASH-related increases in plasma bile acid levels depend on insulin resistanceGuillaume Grzych, Oscar Chávez-Talavera, Amandine Descat, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2018
Combinatorial regulation of hepatic cytoplasmic signaling and nuclear transcriptional events by the OGT/REV-ERBα complexAlexandre Berthier, Manjula Vinod, Geoffrey Porez, et al.
The Journal of Clinical Investigation|February 18, 2014
Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalkFleur Lien, Alexandre Berthier, Emmanuel Bouchaert, et al.
Nature Communications|August 21, 2024
Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASHLaurent L'homme, Benan Pelin Sermikli, Joel T Haas, et al.
Hepatology Communications|March 7, 2020
Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPKAna Sandoval-Rodriguez, Hugo Christian Monroy-Ramirez, Alejandra Meza-Rios, et al.
Scientific Reports|July 10, 2026
Intestinal FXR deficiency uncouples steatosis protection from liver inflammation and fibrosis in MASH-diet fed miceMargaux Nawrot, Simon Peschard, Morgane M Thibaut, et al.
Molecular Metabolism|February 6, 2023
Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasisHélène Dehondt, Arianna Marino, Laura Butruille, et al.
Obesity (Silver Spring, Md.)|November 21, 2023
Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort studyVioleta Raverdy, Estelle Chatelain, Guillaume Lasailly, et al.
Pharmacological Reviews|November 30, 2006
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptorsLiliane Michalik, Johan Auwerx, Joel P Berger, et al.
Pageof 60

Showing results (501-510 of 594) with videos related to

Sort By:
Pageof 60
Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2008
Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosisMarcia L E MacDonald, Miranda van Eck, Reeni B Hildebrand, et al.
JHEP Reports : Innovation in Hepatology|February 22, 2021
NASH-related increases in plasma bile acid levels depend on insulin resistanceGuillaume Grzych, Oscar Chávez-Talavera, Amandine Descat, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2018
Combinatorial regulation of hepatic cytoplasmic signaling and nuclear transcriptional events by the OGT/REV-ERBα complexAlexandre Berthier, Manjula Vinod, Geoffrey Porez, et al.
The Journal of Clinical Investigation|February 18, 2014
Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalkFleur Lien, Alexandre Berthier, Emmanuel Bouchaert, et al.
Nature Communications|August 21, 2024
Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASHLaurent L'homme, Benan Pelin Sermikli, Joel T Haas, et al.
Hepatology Communications|March 7, 2020
Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPKAna Sandoval-Rodriguez, Hugo Christian Monroy-Ramirez, Alejandra Meza-Rios, et al.
Scientific Reports|July 10, 2026
Intestinal FXR deficiency uncouples steatosis protection from liver inflammation and fibrosis in MASH-diet fed miceMargaux Nawrot, Simon Peschard, Morgane M Thibaut, et al.
Molecular Metabolism|February 6, 2023
Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasisHélène Dehondt, Arianna Marino, Laura Butruille, et al.
Obesity (Silver Spring, Md.)|November 21, 2023
Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort studyVioleta Raverdy, Estelle Chatelain, Guillaume Lasailly, et al.
Pharmacological Reviews|November 30, 2006
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptorsLiliane Michalik, Johan Auwerx, Joel P Berger, et al.
Pageof 60